Wells Fargo & Company Announces Common Stock Dividend
SAN FRANCISCO, January 28, 2025--(BUSINESS WIRE)--Wells Fargo & Company (NYSE: WFC) today announced its board of directors approved a quarterly common stock dividend of $0.40 per share, payable March 1, 2025, to stockholders of record on Feb. 7, 2025.
About Wells Fargo
Wells Fargo & Company (NYSE: WFC) is a leading financial services company that has approximately $1.9 trillion in assets. We provide a diversified set of banking, investment and mortgage products and services, as well as consumer and commercial finance, through our four reportable operating segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth & Investment Management. Wells Fargo ranked No. 34 on Fortune's 2024 rankings of America's largest corporations. In the communities we serve, the company focuses its social impact on building a sustainable, inclusive future for all by supporting housing affordability, small business growth, financial health, and a low-carbon economy. News, insights, and perspectives from Wells Fargo are also available at Wells Fargo Stories.
Additional information may be found at www.wellsfargo.com LinkedIn: https://www.linkedin.com/company/wellsfargo
News Release Category: WF-CF
View source version on businesswire.com: https://www.businesswire.com/news/home/20250128049304/en/
Contacts
Contact Information Media Beth Richek, 980-308-1568beth.richek@wellsfargo.com
Investor Relations John Campbell, 415-396-0523john.m.campbell@wellsfargo.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Jack Nathan Health Provides Update on Filing of FY 2024–25 Financial Statements and Audit Progress
TORONTO, June 09, 2025--(BUSINESS WIRE)--Jack Nathan Medical Corp. (TSXV: "JNH"; OTCQB: "JNHMF"), ("Jack Nathan Health", "JNH" or the "Company") announces that it was unable to file its audited consolidated financial statements, management's discussion and analysis (MD&A), and related CEO and CFO certifications for the fiscal year ended January 31, 2025 (collectively, the "Annual Filings") by the required deadline of May 31, 2025. The delay was primarily due to the complexity surrounding the Asset Purchase Agreement (APA) completed on December 1, 2024, under which the Company transferred its Canadian medical clinic business and operations to Well Health Technologies Corp. As part of this transaction, access to EMR systems, supporting documents, and clinical records was also transferred, and this has resulted in extended timelines for data retrieval and audit testing. In addition to the operational handover: The Company underwent a change in external auditors during the fiscal year. A significant number of JNH's employees, including finance and administrative staff, transitioned to Well Health. A resulting delay in commencing the audit, which only began in late February 2025 Despite the late start, Jack Nathan Health made every effort to complete the audit by the filing deadline. Based on that intent, the Company did not apply for a Management Cease Trade Order (MCTO) in advance. However, given the ongoing audit, the Company was unable to meet the statutory filing deadline. As a result, the Ontario Securities Commission issued a Failure-to-File Cease Trade Order ("CTO") against the Company on June 6, 2025, under applicable securities legislation. The CTO prohibits trading in the Company's securities in all Canadian jurisdictions where reciprocal orders apply, until the required filings are completed and the order is revoked. The Company continues to work closely with its auditors to finalize the audit and expects to file well within the 90-day period required for automatic revocation of the CTO. "This past year marked a major transformation for Jack Nathan Health. The transition of our Canadian medical business to Well Health involved an extensive operational and systems handover," said Mike Marchelletta, CEO of Jack Nathan Health. "We recognize the delay in our reporting obligations and remain fully committed to transparency. Our team is working diligently to finalize the audit, and we anticipate filing as soon as possible." About Jack Nathan Medical Corp. Jack Nathan Health® is a provider of MedSpa services in Canada and a former operator of one of the largest retail medical clinic networks in North America. Established in 2006 the Company expanded its international footprint, delivering exceptional, state-of-the-art, turn-key medical centers in 253 locations globally, with 193 corporately owned and operated. In Canada, the Company grew to 82 locations, including 80 clinics in Walmart locations in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, and Quebec and 2 independent locations, with 22 corporate owned and operated clinics of which 3 included Rehab services and 6 included MedSpa services. In Mexico, the Company grew to 171 corporate owned clinics across Mexico within 3 divisions, including 165 retail clinics, 5 clinics inside Walmart Distribution Centers servicing Walmart Associates, and 1 multidisciplinary clinic. In December 2024, Jack Nathan Health restructured its Canadian medical operations through an asset sale to Well Health Technologies Corp. Following the exit from its Walmart Mexico operations in May 2025, the Company continues to operate its Canadian MedSpa clinics and is actively evaluating strategic opportunities for its future business in Canada, Mexico & USA. For more information, visit or Neither the TSX Venture Exchange nor its Regulation Services Provider (as defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Cautionary Note Concerning Going Concern As previously reported by the Company in its consolidated financial statements and related management's discussion and analysis filed on SEDAR+ ( the Company requires additional financing to enable it to continue operations. In the absence of additional financing in the near term, the Company is not expected to have sufficient funds to meet its obligations. The Company is actively pursuing alternatives to raise the necessary additional financing. There can be no assurances that the Company will be able to secure the necessary financing to enable it to continue as a going concern. View source version on Contacts Jack Nathan Medical Corp., Mike Marchelletta, Chief Executive Officer; phone: (647) 488-5008 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
32 minutes ago
- Yahoo
Argan Inc (AGX) Q1 2026 Earnings Call Highlights: Record Backlog and Strong Revenue Growth
Revenue: $193.7 million, a 23% increase year-over-year. Gross Margin: 19%, up from 11.4% in the previous year. Net Income: $22.6 million, or $1.60 per diluted share, compared to $7.9 million, or $0.58 per diluted share, last year. EBITDA: $30.3 million, representing 15.6% of revenue, up from $11.9 million, or 7.5% of revenue, last year. Backlog: Record $1.9 billion as of April 30, 2025. Cash and Investments: $546.5 million with net liquidity of $315 million and no debt. Dividend: Quarterly dividend of $0.375 per share. Share Repurchase: Approximately 100,000 shares repurchased for $12.9 million; program increased to $150 million. Power Industry Services Revenue: Increased 45% to $160 million, representing 83% of first-quarter revenues. Industrial Construction Services Revenue: Decreased to $29 million from $44 million, contributing 15% of first-quarter revenues. Telecommunications Infrastructure Services Revenue: Contributed 2% of first-quarter revenues. Release Date: June 04, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Argan Inc (NYSE:AGX) reported a 23% increase in consolidated revenue to $193.7 million for the first quarter of fiscal 2026. The company achieved a gross margin of 19%, reflecting strong execution and a favorable mix of projects. Argan Inc (NYSE:AGX) reported a record backlog of $1.9 billion as of April 30, 2025, indicating strong future project opportunities. The company's balance sheet remains robust with $546.5 million in cash and investments, and no debt. Argan Inc (NYSE:AGX) increased its quarterly dividend to $0.375 per share and expanded its share repurchase program to $150 million, demonstrating a commitment to returning capital to shareholders. The Industrial Construction Services segment experienced a revenue decrease to $29 million from $44 million in the first quarter of fiscal 2025 due to project timing. The Telecommunications Infrastructure Services segment contributed only 2% of first-quarter revenues, indicating limited growth in this area. Gross margins for the Industrial Construction Services segment decreased to 10.8% from 13.3% in the previous year. The timeline for completing gas-fired power plant projects has extended from 2.5-3 years to 3-4 years, primarily due to supply chain issues. Selling, general, and administrative expenses increased to $12.5 million, although they decreased as a percentage of revenues. Q: Can you provide an update on the pipeline visibility for the rest of the year, especially after the Sandow Lakes project award? A: The pipeline remains strong, and we are optimistic about adding to our backlog, which was $1.9 billion as of April 30. We expect to add several power industrial jobs over the next six months, potentially pushing our backlog significantly over $2 billion. However, project start times are not always within our control, but demand is expected to remain strong for the next decade. Q: What is the potential for backlog growth given your current capacity and project pipeline? A: We anticipate our backlog to grow significantly over $2 billion. We have the capacity to handle multiple projects, including renewable and gas jobs. We recently started several new projects, such as a 700-megawatt power plant, and expect to add more, which should increase our backlog substantially. Q: How does the outlook for the Industrial Business segment look, and what are the revenue trends? A: We anticipated a slight contraction in the past quarter, but we are seeing strong interest in TRC due to increased onshoring of US manufacturing. The TRC backlog increased to $91 million, and we expect revenues to increase significantly over the next several quarters. Q: Can you discuss the recent gross margins and the factors contributing to their increase? A: The recent gross margins reflect strong execution and a changing mix of projects and contract types. We are in a competitive but favorable market and expect to exceed last year's margin profile as we progress through the year. Q: Is the extended project timeline from 2.5-3 years to 3-4 years a permanent change, and what are the contributing factors? A: The extended timeline is primarily supply chain driven. If supply chain issues are resolved, there will be a push for quicker project completion. Currently, the timeline is typically 3-4 years, although smaller jobs may be shorter. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
32 minutes ago
- Yahoo
Argan, Inc. to Announce First Quarter Fiscal 2026 Results and Host Conference Call on Wednesday, June 4, 2025
ARLINGTON, Va., May 21, 2025--(BUSINESS WIRE)--Argan, Inc. (NYSE: AGX) ("Argan" or the "Company") today announced that the Company will release its first quarter 2026 financial results after the market closes on Wednesday, June 4, 2025. Management will host a webcast with an accompanying slide presentation and conference call on Wednesday, June 4, 2025 at 5:00 p.m. ET. Participants can access the live webcast by visiting this link. To access the call by phone, participants can use the following dial-in information: Domestic: 888-506-0062 International: 973-528-0011 Access code: 698123 A replay of the teleconference will be available until June 18, 2025, and can be accessed by dialing 877-481-4010 (domestic) or 919-882-2331 (international). The replay access code is 52474. A replay of the webcast can be accessed until June 4, 2026. About Argan Argan's primary business is providing a full range of construction and related services to the power industry. Argan's service offerings focus on the engineering, procurement and construction of natural gas-fired power plants and renewable energy facilities, along with related commissioning, maintenance, project development and technical consulting services, through its Gemma Power Systems and Atlantic Projects Company operations. Argan also owns The Roberts Company, which is a fully integrated industrial construction, fabrication and plant services company, and SMC Infrastructure Solutions, which provides telecommunications infrastructure services. View source version on Contacts Company Contact: David Watson301.315.0027 Investor Relations: John Nesbett/Jennifer BelodeauIMS Investor Relations203.972.9200argan@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
